| poly-IC, | poly-I:C copolymer of polyinosinic and polycytidylic acids; synthetic RNA polymer |
|---|
| Cop 1 | Copolymer 1 |
|---|---|
| EVAc | Ethylene vinyl acetate copolymer |
| EVAL | ethylene vinyl alcohol copolymer |
| copolymer | A synthetic nucleic acid chain composed of only two nucleotide bases, arranged either in random order (if chain is DNA) or in alternating order (if chain is RNA). A polymer that was made by simultaneously polymerising two or more different monomers. (09 Oct 1997) |
|---|---|
| copolymer resin | Synthetic resin produced by joint polymerization of two or more different monomers or polymers. (05 Mar 2000) |
| pyran copolymer | <chemical> 2,5-furandione polymer with 1,1'-oxybis(ethene). Copolymer of divinyl ether and maleic anhydride that is acts as an immunostimulant with antineoplastic and anti-infective properties. It is used also in combination with other antineoplastic agent. Pharmacological action: antineoplastic agent, antiviral agents, interferon inducers. Chemical name: 2,5-Furandione, polymer with 1,1'-oxybis(ethene) (12 Dec 1998) |
| Copolymer 1 |
(Co
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|---|
| Copolymer 1 |
GA is a synthetic random copolymer of the four amino acids l-glutamic acid, l-lysine, l-alanine, and l-tyrosine (78?0). After clinical trials had shown benefit (81?6), GA was approved for the treatment of relapsing remitting MS. The beneficial effects of GA were subsequently confirmed by MRI studies (87). Compared with the MRI-confirmed effects of IFN-? those of GA are delayed (87). This delay appears to be consistent with the time course of the GA-induced immunological changes (88).
출처: www.pubmedcentral.nih.gov/articlerender.fcgi
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|